U.S. markets open in 2 hours 54 minutes

Aprea Therapeutics, Inc. (APRE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.2800+0.0500 (+1.18%)
At close: 4:00PM EDT
4.3000 +0.02 (0.47%)
Pre-Market: 06:08AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/31/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
89.62M108.05M104.24M509.76M816.51M
Enterprise Value 3
12.26M19.37M3.47M397.32M694.46M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
1.301.401.175.097.25
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-0.24-1.92-0.24-32.63-48.12

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-85.32%
S&P500 52-Week Change 332.93%
52 Week High 331.4500
52 Week Low 33.8800
50-Day Moving Average 34.9147
200-Day Moving Average 35.1815

Share Statistics

Avg Vol (3 month) 33.46M
Avg Vol (10 day) 3697.02k
Shares Outstanding 521.19M
Implied Shares Outstanding 6N/A
Float 15.49M
% Held by Insiders 110.14%
% Held by Institutions 152.57%
Shares Short (Jul 14, 2021) 41.09M
Short Ratio (Jul 14, 2021) 40.14
Short % of Float (Jul 14, 2021) 45.89%
Short % of Shares Outstanding (Jul 14, 2021) 45.15%
Shares Short (prior month Jun 14, 2021) 41.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.10%
Return on Equity (ttm)-58.90%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -51.1M
Net Income Avi to Common (ttm)-53.75M
Diluted EPS (ttm)-2.5390
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)77.62M
Total Cash Per Share (mrq)3.66
Total Debt (mrq)259.3k
Total Debt/Equity (mrq)0.38
Current Ratio (mrq)7.14
Book Value Per Share (mrq)3.26

Cash Flow Statement

Operating Cash Flow (ttm)-45.78M
Levered Free Cash Flow (ttm)-26.53M